Motion sickness happens when the brain receives conflicting signals about motion from the eyes and inner ear, triggering autonomic responses. The most characteristic signs are nausea along with pallor (pale skin) and cold sweats, reflecting sympathetic activation. Nausea is the most prominent symptom, and the combination of pallor and sweating makes this trio the classic presentation. Headache can occur but isn’t as specific, rash isn’t related to motion sickness, and dizziness may occur but isn’t the defining cluster of signs.

Exposure to toxic fuels tends to show up with nervous system and respiratory effects. Inhaled fuels can cause lightheadedness and confusion as the CNS is affected, and fatigue is a common nonspecific symptom of exposure. Coughing often results from airway irritation due to fumes. Chills, on the other hand, are not typically listed as a symptom of toxic fuel exposure; they’re more commonly associated with fever or cold exposure, not inhalation injuries. So the symptom that does not fit the usual exposure pattern is chills.

The concept is rod-dominated, low-light vision. Scotopic vision describes this state where rods are the primary active photoreceptors in dim conditions. Rods are extremely sensitive to light, which lets you see at night, but they give grayscale vision and poorer detail since they do not convey color. Cones, which provide color and sharp detail, require more light and hence operate mainly in photopic (daylight) vision. In between, mesopic vision is when both rods and cones contribute. So night vision with rods only is scotopic vision.

Motion sickness medications in aviation are regulated because they can affect performance, so some drugs are only allowed with supervision and for a limited number of flights. The option that matches the rule is promethazine with ephedrine. Promethazine helps prevent motion sickness, and ephedrine provides a mild stimulant effect to counteract drowsiness, helping maintain alertness during flight. This combination has historically been approved for use with up to three flights under the accompaniment of an instructor pilot, fitting the requirement you’re asked about. The other medications either don’t align with that supervised, limited-flight rule or aren’t used in this context for motion sickness: scopolamine is more likely to impair performance or carry stricter restrictions; dexedrine is a stimulant not used for motion sickness with this flight-rule framework; metoclopramide is an antiemetic without the specific three-flight supervision allowance.